دورية أكاديمية

Clinical prediction rules for the diagnosis of neuritis in leprosy.

التفاصيل البيبلوغرافية
العنوان: Clinical prediction rules for the diagnosis of neuritis in leprosy.
المؤلفون: Giesel LM; Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21240-360, Brazil. louisegiesel@gmail.com.; Post-Graduate Program in Neurology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. louisegiesel@gmail.com., Hökerberg YHM; Laboratory of Clinical Epidemiology, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz, Brazil.; School of Medicine, Estácio de Sá University, Rio de Janeiro, Brazil., Pitta IJR; Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21240-360, Brazil.; Post-Graduate Program in Neurology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Andrade LR; Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21240-360, Brazil.; Post-Graduate Program in Neurology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Moraes DB; Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21240-360, Brazil.; Post-Graduate Program in Neurology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., da Costa Nery JA; Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21240-360, Brazil., Sarno EN; Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21240-360, Brazil., Jardim MR; Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21240-360, Brazil.; Post-Graduate Program in Neurology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.; Department of Neurology, Pedro Ernesto University Hospital/Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil.
المصدر: BMC infectious diseases [BMC Infect Dis] 2021 Aug 23; Vol. 21 (1), pp. 858. Date of Electronic Publication: 2021 Aug 23.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Leprosy*/complications , Leprosy*/diagnosis , Neuralgia* , Neuritis*/diagnosis, Brazil ; Clinical Decision Rules ; Cross-Sectional Studies ; Humans
مستخلص: Background: Diagnosing neuritis in leprosy patients with neuropathic pain or chronic neuropathy remains challenging since no specific laboratory or neurophysiological marker is available.
Methods: In a cross-sectional study developed at a leprosy outpatient clinic in Rio de Janeiro, RJ, Brazil, 54 individuals complaining of neural pain (single or multiple sites) were classified into two groups ("neuropathic pain" or "neuritis") by a neurological specialist in leprosy based on anamnesis together with clinical and electrophysiological examinations. A neurologist, blind to the pain diagnoses, interviewed and examined the participants using a standardized form that included clinical predictors, pain features, and neurological symptoms. The association between the clinical predictors and pain classifications was evaluated via the Pearson Chi-Square or Fisher's exact test (p < 0.05).
Results: Six clinical algorithms were generated to evaluate sensitivity and specificity, with 95% confidence intervals, for clinical predictors statistically associated with neuritis. The most conclusive clinical algorithm was: pain onset at any time during the previous 90 days, or in association with the initiation of neurological symptoms during the prior 30-day period, necessarily associated with the worsening of pain upon movement and nerve palpation, with 94% of specificity and 35% of sensitivity.
Conclusion: This algorithm could help physicians confirm neuritis in leprosy patients with neural pain, particularly in primary health care units with no access to neurologists or electrophysiological tests.
(© 2021. The Author(s).)
References: Clin Dermatol. 2016 Jan-Feb;34(1):59-65. (PMID: 26773624)
Rev Soc Bras Med Trop. 2008 Sep-Oct;41(5):464-9. (PMID: 19009187)
Science. 2002 May 3;296(5569):927-31. (PMID: 11988579)
Brain Behav. 2012 May;2(3):249-55. (PMID: 22741099)
Infect Dis Poverty. 2016 Mar 07;5:18. (PMID: 26951147)
Rev Lat Am Enfermagem. 2016 Aug 8;24:e2731. (PMID: 27508904)
Am J Trop Med Hyg. 2018 Jun;98(6):1609-1613. (PMID: 29611495)
Lepr Rev. 2000 Dec;71 Suppl:S106-10. (PMID: 11201864)
Lepr Rev. 2015 Dec;86(4):356-67. (PMID: 26964431)
J Clin Neurophysiol. 2011 Jun;28(3):329-32. (PMID: 21633262)
Science. 1998 Dec 11;282(5396):2076-9. (PMID: 9851927)
Pathog Glob Health. 2014 Jun;108(4):186-90. (PMID: 24892791)
Pain Rep. 2018 Feb 23;3(2):e638. (PMID: 29756085)
Clin Neurol Neurosurg. 2015 Apr;131:5-10. (PMID: 25655301)
Pain. 2012 Aug;153(8):1620-1624. (PMID: 22727538)
Clin Dermatol. 2016 Jan-Feb;34(1):37-50. (PMID: 26773622)
Pain. 2011 Jan;152(1):14-27. (PMID: 20851519)
J Hand Ther. 1997 Apr-Jun;10(2):122-9. (PMID: 9188031)
Clin Dermatol. 2016 Jan-Feb;34(1):51-8. (PMID: 26773623)
PLoS Negl Trop Dis. 2018 Jul 2;12(7):e0006610. (PMID: 29965957)
Rev Soc Bras Med Trop. 2016 Nov-Dec;49(6):741-745. (PMID: 28001221)
J Neuropathol Exp Neurol. 2016 Mar;75(3):272-83. (PMID: 26888306)
BMJ. 2014 Feb 05;348:f7656. (PMID: 24500412)
Clin Dermatol. 2015 Jan-Feb;33(1):46-54. (PMID: 25432810)
فهرسة مساهمة: Keywords: Clinical prediction rules; Leprosy; Neuritis; Neuropathic pain; Sensitivity; Specificity
تواريخ الأحداث: Date Created: 20210824 Date Completed: 20210924 Latest Revision: 20210924
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8381570
DOI: 10.1186/s12879-021-06545-2
PMID: 34425777
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2334
DOI:10.1186/s12879-021-06545-2